Aktis Oncology, Inc. (AKTS)

Aktis Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-73.14	-63.73	-43.98	-28.64	-17.93
Depreciation & Amortization	2.82	2.33	1.58	1.12	0.45
Loss (Gain) From Sale of Investments	-3.02	-4.62	-4.08	-3.15	-
Stock-Based Compensation	8.62	5.13	2.26	1.48	0.7
Other Operating Activities	-	-	0.01	-0.8	-0.2
Change in Accounts Payable	0.73	-0.04	0.36	0.66	-0
Change in Unearned Revenue	-9.06	-5.5	58.51	-	-
Change in Other Net Operating Assets	-2.26	2.31	0.11	-0.67	-1.14
Operating Cash Flow	-75.29	-64.13	14.76	-30	-18.13
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Capital Expenditures	-9.27	-9.58	-2.86	-3.76	-2.31
Sale of Property, Plant & Equipment	-	-	-	0.06	-
Investment in Securities	-280.12	75.55	-187.54	-65.12	-
Investing Cash Flow	-289.39	65.96	-190.4	-68.83	-2.31

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Issuance of Common Stock	340.25	0.34	0.18	-	-
Other Financing Activities	-3.29	-1.55	-1.9	-	-0.15
Financing Cash Flow	336.96	-1.21	183.28	-	119.98

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Cash Flow	-27.72	0.63	7.65	-98.83	99.55

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Free Cash Flow	-84.57	-73.71	11.9	-33.77	-20.43
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Margin	-840.62%	-1134.54%	800.27%	-	-
Free Cash Flow Per Share	-3.20	-90.61	16.90	-54.89	-39.49
Levered Free Cash Flow	-	-36.24	-20.08	-21.08	-
Unlevered Free Cash Flow	-	-36.24	-20.08	-21.08	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Change in Working Capital	-10.58	-3.23	58.98	-0.02	-1.14

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error